Allogene Therapeutics (ALLO)

Allogene Therapeutics (ALLO) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• ALLO last traded at $1.18, -5.60% on the day.
• Allogene Therapeutics: market cap $407.68M, P/E -1.6, revenue $4.64M over the last four quarters, next earnings 2026-11-05.
• Over the past year ALLO returned -2.48%; year to date -13.87%.

Updated 2026-11-02 17:49 UTC